Anticoagulants Market
Anticoagulants Market Analysis By Drug Class (Factor X Inhibitor (NOAC/DOAC) Anticoagulants, Heparin Anticoagulants, Direct Thrombin Inhibitor Anticoagulants, Vitamin K Antagonist Anticoagulants), By Route of Administration, By Indication - Global Market Insights 2021 to 2031
Analysis of Anticoagulants market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Table of Content
1. Preface 1.1. Market Definition and Scope 1.2. Market Segmentation 1.3. Key Research Objectives 1.4. Research Highlights 2. Assumptions and Research Methodology 3. Executive Summary: Global Anticoagulants Market 4. Market Overview 4.1. Introduction 4.1.1. Route of Administration Definition 4.1.2. Industry Evolution / Developments 4.2. Overview 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.3.4. Market Trends 4.4. Global Anticoagulants market analysis and Forecast, 2016–2031 4.5. Porter’s Five Force Analysis 5. Market Outlook 5.1. Key Mergers & Acquisitions 6. Global Anticoagulants Market Analysis and Forecast, by Route of Administration 6.1. Introduction & Definition 6.2. Key Findings / Developments 6.3. Market Value Forecast, by Route of Administration, 2016–2031 6.3.1. Oral 6.3.2. Injectable 6.4. Market Attractiveness, by Route of Administration 7. Global Anticoagulants Market Analysis and Forecast, by Drug Class 7.1. Introduction & Definition 7.2. Key Findings / Developments 7.3. Market Value Forecast, by Drug Class, 2016–2031 7.3.1. Factor XA Inhibitors (NOAC/DOAC) 7.3.2. Heparins 7.3.3. Direct Thrombin Inhibitors 7.3.4. Vitamin K Antagonists 7.4. Market Attractiveness, by Drug Class 8. Global Anticoagulants Market Analysis and Forecast, by Indication 8.1. Introduction & Definition 8.2. Key Findings / Developments 8.3. Market Value Forecast, by Distribution Channel, 2016–2031 8.3.1. Deep Vein Thrombosis 8.3.2. Pulmonary Embolism 8.3.3. Atrial Fibrillation & Heart Attack 8.3.4. Others 8.4. Market Attractiveness, by Distribution Channel 9. Global Anticoagulants Market Analysis and Forecast, by Distribution Channel 9.1. Introduction & Definition 9.2. Key Findings / Developments 9.3. Market Value Forecast, by Distribution Channel, 2016–2031 9.3.1. Hospital Pharmacies 9.3.2. Retail Pharmacies 9.3.3. Online Pharmacies 9.4. Market Attractiveness, by Distribution Channel 10. Global Anticoagulants Market Analysis and Forecast, by Region 10.1. Key Findings 10.2. Market Value Forecast, by Region 10.2.1. North America 10.2.2. Europe 10.2.3. Asia Pacific 10.2.4. Latin America 10.2.5. Middle East & Africa 10.3. Market Attractiveness, by Region 11. North America Anticoagulants Market Analysis and Forecast 11.1. Introduction 11.1.1. Key Findings 11.2. Market Value Forecast, by Route of Administration, 2016–2031 11.2.1. Oral 11.2.2. Injectables 11.3. Market Value Forecast, by Drug Class, 2016–2031 11.3.1. Factor XA Inhibitors (NOAC/DOAC) 11.3.2. Heparins 11.3.3. Direct Thrombin Inhibitors 11.3.4. Vitamin K Antagonists 11.4. Market Value Forecast, by Distribution Channel, 2016–2031 11.4.1. Deep Vein Thrombosis 11.4.2. Pulmonary Embolism 11.4.3. Atrial Fibrillation & Heart Attack 11.4.4. Others 11.5. Market Value Forecast, by Distribution Channel, 2016–2031 11.5.1. Hospital Pharmacies 11.5.2. Retail Pharmacies 11.5.3. Online Pharmacies 11.6. Market Value Forecast, by Country, 2016–2031 11.6.1. U.S. 11.6.2. Canada 11.7. Market Attractiveness Analysis 11.7.1. By Route of Administration 11.7.2. By Drug Class 11.7.3. By Indication 11.7.4. By Distribution Channel 11.7.5. By Country 12. Europe Anticoagulants Market Analysis and Forecast 12.1. Introduction 12.1.1. Key Findings 12.2. Market Value Forecast, by Route of Administration, 2016–2031 12.2.1. Oral 12.2.2. Injectables 12.3. Market Value Forecast, by Drug Class, 2016–2031 12.3.1. Factor XA Inhibitors (NOAC/DOAC) 12.3.2. Heparins 12.3.3. Direct Thrombin Inhibitors 12.3.4. Vitamin K Antagonists 12.4. Market Value Forecast, by Distribution Channel, 2016–2031 12.4.1. Deep Vein Thrombosis 12.4.2. Pulmonary Embolism 12.4.3. Atrial Fibrillation & Heart Attack 12.4.4. Others 12.5. Market Value Forecast, by Distribution Channel, 2016–2031 12.5.1. Hospital Pharmacies 12.5.2. Retail Pharmacies 12.5.3. Online Pharmacies 12.6. Market Value Forecast, by Country/Sub-region, 2016–2031 12.6.1. Germany 12.6.2. U.K. 12.6.3. France 12.6.4. Italy 12.6.5. Spain 12.6.6. Rest of Europe 12.7. Market Attractiveness Analysis 12.7.1. By Route of Administration 12.7.2. By Drug Class 12.7.3. By Indication 12.7.4. By Distribution Channel 12.7.5. By Country/Sub-Region 13. Asia Pacific Anticoagulants Market Analysis and Forecast 13.1. Introduction 13.1.1. Key Findings 13.2. Market Value Forecast, by Route of Administration, 2016–2031 13.2.1. Oral 13.2.2. Injectables 13.3. Market Value Forecast, by Drug Class, 2016–2031 13.3.1. Factor XA Inhibitors (NOAC/DOAC) 13.3.2. Heparins 13.3.3. Direct Thrombin Inhibitors 13.3.4. Vitamin K Antagonists 13.4. Market Value Forecast, by Distribution Channel, 2016–2031 13.4.1. Deep Vein Thrombosis 13.4.2. Pulmonary Embolism 13.4.3. Atrial Fibrillation & Heart Attack 13.4.4. Others 13.5. Market Value Forecast, by Distribution Channel, 2016–2031 13.5.1. Hospital Pharmacies 13.5.2. Retail Pharmacies 13.5.3. Online Pharmacies 13.6. Market Value Forecast, by Country/Sub-region, 2016–2031 13.6.1. Japan 13.6.2. China 13.6.3. India 13.6.4. Australia & New Zealand 13.6.5. Rest of Asia Pacific 13.7. Market Attractiveness Analysis 13.7.1. By Route of Administration 13.7.2. By Drug Class 13.7.3. By Indication 13.7.4. By Distribution Channel 13.7.5. By Country/Sub-Region 14. Latin America Anticoagulants Market Analysis and Forecast 14.1. Introduction 14.1.1. Key Findings 14.2. Market Value Forecast, by Route of Administration, 2016–2031 14.2.1. Oral 14.2.2. Injectables 14.3. Market Value Forecast, by Drug Class, 2016–2031 14.3.1. Factor XA Inhibitors (NOAC/DOAC) 14.3.2. Heparins 14.3.3. Direct Thrombin Inhibitors 14.3.4. Vitamin K Antagonists 14.4. Market Value Forecast, by Distribution Channel, 2016–2031 14.4.1. Deep Vein Thrombosis 14.4.2. Pulmonary Embolism 14.4.3. Atrial Fibrillation & Heart Attack 14.4.4. Others 14.5. Market Value Forecast, by Distribution Channel, 2016–2031 14.5.1. Hospital Pharmacies 14.5.2. Retail Pharmacies 14.5.3. Online Pharmacies 14.6. Market Value Forecast, by Country/Sub-region, 2016–2031 14.6.1. Brazil 14.6.2. Mexico 14.6.3. Rest of Latin America 14.7. Market Attractiveness Analysis 14.7.1. By Route of Administration 14.7.2. By Drug Class 14.7.3. By Indication 14.7.4. By Distribution Channel 14.7.5. By Country/Sub-Region 15. Middle East & Africa Anticoagulants Market Analysis and Forecast 15.1. Introduction 15.1.1. Key Findings 15.2. Market Value Forecast, by Route of Administration, 2016–2031 15.2.1. Oral 15.2.2. Injectables 15.3. Market Value Forecast, by Drug Class, 2016–2031 15.3.1. Factor XA Inhibitors (NOAC/DOAC) 15.3.2. Heparins 15.3.3. Direct Thrombin Inhibitors 15.3.4. Vitamin K Antagonists 15.4. Market Value Forecast, by Distribution Channel, 2016–2031 15.4.1. Deep Vein Thrombosis 15.4.2. Pulmonary Embolism 15.4.3. Atrial Fibrillation & Heart Attack 15.4.4. Others 15.5. Market Value Forecast, by Distribution Channel, 2016–2031 15.5.1. Hospital Pharmacies 15.5.2. Retail Pharmacies 15.5.3. Online Pharmacies 15.6. Market Value Forecast, by Country/Sub-region, 2016–2031 15.6.1. GCC Countries 15.6.2. Israel 15.6.3. South Africa 15.6.4. Rest of Middle East & Africa 15.7. Market Attractiveness Analysis 15.7.1. By Route of Administration 15.7.2. By Drug Class 15.7.3. By Distribution Channel 15.7.4. By Indication 15.7.5. By Country/Sub-Region 16. Competition Landscape 16.1. Market Player - Competition Matrix 16.2. Market Share Analysis, by Company (2017) 16.3. Company Profiles 16.4. Bayer AG 16.4.1. Company Overview (HQ, Business Segments, Employee Strength) 16.4.2. Financial Overview 16.4.3. Product Portfolio 16.4.4. SWOT Analysis 16.4.5. Strategic Overview 16.5. Boehringer Ingelheim International GmbH 16.5.1. Company Overview (HQ, Business Segments, Employee Strength) 16.5.2. Financial Overview 16.5.3. Product Portfolio 16.5.4. SWOT Analysis 16.5.5. Strategic Overview 16.6. Bristol-Myers Squibb Company 16.6.1. Company Overview (HQ, Business Segments, Employee Strength) 16.6.2. Financial Overview 16.6.3. Product Portfolio 16.6.4. SWOT Analysis 16.6.5. Strategic Overview 16.7. Daiichi Sankyo Company, Limited 16.7.1. Company Overview (HQ, Business Segments, Employee Strength) 16.7.2. Financial Overview 16.7.3. Product Portfolio 16.7.4. SWOT Analysis 16.7.5. Strategic Overview 16.8. Sanofi 16.8.1. Company Overview (HQ, Business Segments, Employee Strength) 16.8.2. Financial Overview 16.8.3. Product Portfolio 16.8.4. SWOT Analysis 16.8.5. Strategic Overview 16.9. Johnson & Johnson Services 16.9.1. Company Overview (HQ, Business Segments, Employee Strength) 16.9.2. Financial Overview 16.9.3. Product Portfolio 16.9.4. SWOT Analysis 16.9.5. Strategic Overview
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Anticoagulants Market Value (US$ Mn) Forecast, by Route of Administration, 2016–2031
Table 02: Global Anticoagulants Market Value (US$ Mn) Forecast, by Drug Class, 2016–2031
Table 03: Global Anticoagulants Market Value (US$ Mn) Forecast, by Indication, 2016–2031
Table 04: Global Anticoagulants Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2031
Table 05: Global Anticoagulants Market Size (US$ Mn) and Volume (Units) Forecast, by Region, 2021–2031
Table 06: North America Anticoagulants Market Value (US$ Mn) Forecast, by Country, 2016–2031
Table 07: North America Anticoagulants Market Value (US$ Mn) Forecast, by Route of Administration, 2016–2031
Table 08: North America Anticoagulants Market Value (US$ Mn) Forecast, by Drug Class, 2016–2031
Table 09: North America Anticoagulants Market Value (US$ Mn) Forecast, by Indication, 2016–2031
Table 10: North America Anticoagulants Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2031
Table 11: Europe Anticoagulants Size Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2031
Table 12: Europe Anticoagulants Market Value (US$ Mn) Forecast, by Route of Administration, 2016–2031
Table 13: Europe Anticoagulants Market Value (US$ Mn) Forecast, by Drug Class, 2016–2031
Table 14: Europe Anticoagulants Market Value (US$ Mn) Forecast, by Indication, 2016–2031
Table 15: Europe Anticoagulants Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2031
Table 16: Asia Pacific Anticoagulants Size Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2031
Table 17: Asia Pacific Anticoagulants Market Value (US$ Mn) Forecast, by Route of Administration, 2016–2031
Table 18: Asia Pacific Anticoagulants Market Value (US$ Mn) Forecast, by Drug Class, 2016–2031
Table 19: Asia Pacific Anticoagulants Market Value (US$ Mn) Forecast, by Indication, 2016–2031
Table 20: Asia Pacific Anticoagulants Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2031
Table 21: Latin America Anticoagulants Size Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2031
Table 22: Latin America Anticoagulants Market Value (US$ Mn) Forecast, by Route of Administration, 2016–2031
Table 23: Latin America Anticoagulants Market Value (US$ Mn) Forecast, by Drug Class, 2016–2031
Table 24: Latin America Anticoagulants Market Value (US$ Mn) Forecast, by Indication, 2016–2031
Table 25: Latin America Anticoagulants Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2031
Table 26: Middle East & Africa Anticoagulants Size Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2031
Table 27: Middle East & Africa Anticoagulants Market Value (US$ Mn) Forecast, by Route of Administration, 2016–2031
Table 28: Middle East & Africa Anticoagulants Market Value (US$ Mn) Forecast, by Drug Class, 2016–2031
Table 29: Middle East & Africa Anticoagulants Market Value (US$ Mn) Forecast, by Indication, 2016–2031
Table 30: Middle East & Africa Anticoagulants Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2031
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Anticoagulants Market Size Value (US$ Mn) Forecast, 2016–2031
Figure 02: Global Anticoagulants Market Value Share (%), by Route of Administration, 2021
Figure 03: Global Anticoagulants Market Value Share (%), by Drug Class, 2021
Figure 04: Global Anticoagulants Market Value Share (%), by End-user, 2021
Figure 05: Global Anticoagulants Market Value Share (%), by Region, 2021
Figure 06: Global Anticoagulants Market Value Share, by Route of Administration, 2021 and 2031
Figure 07: Global Anticoagulants Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Oral, 2016–2031
Figure 08: Global Anticoagulants Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Injectables, 2016–2031
Figure 09: Global Anticoagulants Market Attractiveness, by Route of Administration, 2021–2031
Figure 10: Global Anticoagulants Market Value Share, by Drug Class, 2021 and 2031
Figure 11: Global Anticoagulants Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Factor XA Inhibitors, 2016–2031
Figure 12: Global Anticoagulants Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Heparins, 2016–2031
Figure 13: Global Anticoagulants Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Direct Thrombin Inhibitors, 2016–2031
Figure 14: Global Anticoagulants Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Vitamin K Antagonists, 2016–2031
Figure 15: Global Anticoagulants Market Attractiveness, by Drug Class, 2021–2031
Figure 16: Global Anticoagulants Market Value Share, by Indication, 2021 and 2031
Figure 17: Global Anticoagulants Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Deep Vein Thrombosis (DVT), 2016–2031
Figure 18: Global Anticoagulants Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Pulmonary Embolism (PE), 2016–2031
Figure 19: Global Anticoagulants Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Atrial Fibrillation & Heart Attack, 2016–2031
Figure 20: Global Anticoagulants Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2016–2031
Figure 21: Global Anticoagulants Market Attractiveness, by Indication, 2021–2031
Figure 22: Global Anticoagulants Market Value Share, by Distribution Channel, 2021 and 2031
Figure 23: Global Anticoagulants Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospitals Pharmacies, 2016–2031
Figure 24: Global Anticoagulants Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Retail Pharmacies, 2016–2031
Figure 25: Global Anticoagulants Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Online Pharmacies, 2016–2031
Figure 26: Global Anticoagulants Market Attractiveness, by Distribution Channel, 2021–2031
Figure 27: Global Anticoagulants Market Value Share Analysis, by Region, 2021 and 2031
Figure 28: Global Anticoagulants Market Attractiveness Analysis, by Region, 2021 and 2031
Figure 29: North America Anticoagulants Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2031
Figure 30: North America Anticoagulants Market Value Share, by Country, 2021 and 2031
Figure 31: North America Anticoagulants Market Attractiveness, by Country, 2021–2031
Figure 32: North America Anticoagulants Market Value Share, by Route of Administration, 2021 and 2031
Figure 33: North America Anticoagulants Market Attractiveness, by Route of Administration, 2021–2031
Figure 34: North America Anticoagulants Market Value Share, by Drug Class, 2021 and 2031
Figure 35: North America Anticoagulants Market Attractiveness, by Drug Class, 2021–2031
Figure 36: North America Anticoagulants Market Value Share, by Indication, 2021 and 2031
Figure 37: North America Anticoagulants Market Attractiveness, by Indication, 2021–2031
Figure 38: North America Anticoagulants Market Value Share, by Distribution Channel, 2021 and 2031
Figure 39: North America Anticoagulants Market Attractiveness, by Distribution Channel, 2021–2031
Figure 40: Europe Anticoagulants Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2031
Figure 41: Europe Anticoagulants Market Value Share, by Country/Sub-region, 2021 and 2031
Figure 42: Europe Anticoagulants Market Attractiveness, by Country/Sub-region, 2021–2031
Figure 43: Europe Anticoagulants Market Value Share, by Route of Administration, 2021 and 2031
Figure 44: Europe Anticoagulants Market Attractiveness, by Route of Administration, 2021–2031
Figure 45: Europe Anticoagulants Market Value Share, by Drug Class, 2021 and 2031
Figure 46: Europe Anticoagulants Market Attractiveness, by Drug Class, 2021–2031
Figure 47: Europe Anticoagulants Market Value Share, by Indication, 2021 and 2031
Figure 48: Europe Anticoagulants Market Attractiveness, by Indication, 2021–2031
Figure 49: Europe Anticoagulants Market Value Share, by Distribution Channel, 2021 and 2031
Figure 50: Europe Anticoagulants Market Attractiveness, by Distribution Channel, 2021–2031
Figure 51: Asia Pacific Anticoagulants Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2031
Figure 52: Asia Pacific Anticoagulants Market Value Share, by Country/Sub-region, 2021 and 2031
Figure 53: Asia Pacific Anticoagulants Market Attractiveness, by Country/Sub-region, 2021–2031
Figure 54: Asia Pacific Anticoagulants Market Value Share, by Route of Administration, 2021 and 2031
Figure 55: Asia Pacific Anticoagulants Market Attractiveness, by Route of Administration, 2021–2031
Figure 56: Asia Pacific Anticoagulants Market Value Share, by Drug Class, 2021 and 2031
Figure 57: Asia Pacific Anticoagulants Market Attractiveness, by Drug Class, 2021–2031
Figure 58: Asia Pacific Anticoagulants Market Value Share, by Indication, 2021 and 2031
Figure 59: Asia Pacific Anticoagulants Market Attractiveness, by Indication, 2021–2031
Figure 60: Asia Pacific Anticoagulants Market Value Share, by Distribution Channel, 2021 and 2031
Figure 61: Asia Pacific Anticoagulants Market Attractiveness, by Distribution Channel, 2021–2031
Figure 62: Latin America Anticoagulants Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2031
Figure 63: Latin America Anticoagulants Market Value Share, by Country/Sub-region, 2021 and 2031
Figure 64: Latin America Anticoagulants Market Attractiveness, by Country/Sub-region, 2021–2031
Figure 65: Latin America Anticoagulants Market Value Share, by Route of Administration, 2021 and 2031
Figure 66: Latin America Anticoagulants Market Attractiveness, by Route of Administration, 2021–2031
Figure 67: Latin America Anticoagulants Market Value Share, by Drug Class, 2021 and 2031
Figure 68: Latin America Anticoagulants Market Attractiveness, by Drug Class, 2021–2031
Figure 69: Latin America Anticoagulants Market Value Share, by Indication, 2021 and 2031
Figure 70: Latin America Anticoagulants Market Attractiveness, by Indication, 2021–2031
Figure 71: Latin America Anticoagulants Market Value Share, by Distribution Channel, 2021 and 2031
Figure 72: Latin America Anticoagulants Market Attractiveness, by Distribution Channel, 2021–2031
Figure 73: Middle East & Africa Anticoagulants Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2031
Figure 74: Middle East & Africa Anticoagulants Market Value Share, by Country/Sub-region, 2021 and 2031
Figure 75: Middle East & Africa Anticoagulants Market Attractiveness, by Country/Sub-region, 2021–2031
Figure 76: Middle East & Africa Anticoagulants Market Value Share, by Route of Administration, 2021 and 2031
Figure 77: Middle East & Africa Anticoagulants Market Attractiveness, by Route of Administration, 2021–2031
Figure 78: Middle East & Africa Anticoagulants Market Value Share, by Drug Class, 2021 and 2031
Figure 79: Middle East & Africa Anticoagulants Market Attractiveness, by Drug Class, 2021–2031
Figure 80: Middle East & Africa Anticoagulants Market Value Share, by Indication, 2021 and 2031
Figure 81: Middle East & Africa Anticoagulants Market Attractiveness, by Indication, 2021–2031
Figure 82: Middle East & Africa Anticoagulants Market Value Share, by Distribution Channel, 2021 and 2031
Figure 83: Middle East & Africa Anticoagulants Market Attractiveness, by Distribution Channel, 2021–2031
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request